The proposed MyPEEPS intervention for young transgender men is a novel and evidence-driven intervention using mobile technology to deliver HIV prevention information to high risk youth. The final product will be the basis for conducting a large-scale efficacy study in this population.
Transgender youth in the United States have unique health needs but often face barriers to accessing and receiving health care services which contribute to disparate health outcomes including high vulnerability to HIV and other sexually transmitted infections. Emerging evidence has begun to document HIV-related sexual risk among young transgender men (YTM), as well as low uptake of pre-exposure prophylaxis among those with indications, suggesting high vulnerability to HIV infection. Despite the high prevalence and increased risk of HIV in YTM who have sex with cisgender men, only one prior HIV prevention intervention has been developed to address the specific sexual health needs of YTM, which indicates a critical gap in HIV prevention science. In response to this need, and building off preliminary work, the investigators propose to develop a mobile intervention for YTM building on MyPEEPS Mobile, which was originally developed for very young sexual minority men. Central to this intervention is the premise that it will be delivered to youth during a developmental period that precedes or coincides with sexual debut, an important time for intervention, prior to or concurrent with initiation of high-risk behaviors. Given both the gap in HIV prevention science and the lack of current targeted interventions, and building upon our multidisciplinary team's extensive experience in HIV prevention, mobile health (mHealth), behavioral interventions, randomized controlled trials, and transgender health, the investigators propose the following specific aims: 1) Using qualitative methodology, expert feedback, and usability assessments, develop MyPEEPS Mobile for YTM, 2) Conduct a pilot randomized controlled trial to examine the feasibility, acceptability, and preliminary efficacy of the revised MyPEEPS Mobile App in a sample of 80 YTM (15-25 years) and refine the study methods for a future efficacy trial, and 3) Assess predisposing, enabling, and reinforcing factors for MyPEEPS Mobile among YTM through theoretically-guided in depth interviews. The proposed MyPEEPS intervention for YTM will be the first study to develop and pilot a scaled-up, mobile HIV prevention intervention designed by, and piloted for, a diverse group of YTM. The final product of this study will be the basis for an R01 application to conduct a large-scale efficacy study for this population.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Enrollment
80
Mobile technology to deliver HIV prevention information specifically developed for at-risk young men that have sex with men (YMSM).
Ann & Robert H. Lurie Children's Hospital Chicago
Chicago, Illinois, United States
Callen-Lorde Community Health Center
New York, New York, United States
Columbia University
New York, New York, United States
Change in Condomless Receptive Sex Acts
Change in self-reported number of condomless receptive anal or vaginal sex acts with sex partners assigned male at birth
Time frame: Baseline, 3 and 6 months
Self-reported Nonoccupational HIV Postexposure Prophylaxis (nPEP) Use
Number of participants that self-reported nPEP use
Time frame: 3 and 6 months
Self-reported Pre-exposure Prophylaxis (PrEP) Use
Number of participants that self-reported Pre-exposure Prophylaxis (PrEP) Use
Time frame: 3 and 6 months
Self-reported HIV Testing
Number of participants that self-reported HIV testing
Time frame: 3 and 6 months
Self-reported Sexually Transmitted Infections (STI) Testing
Number of participants that self-reported STI Testing
Time frame: 3 and 6 months
Change in Partner PrEP Use and Adherence or Viral Suppression
Change in participant's self-report of their partner(s) PrEP use and adherence or viral suppression (if partner(s) is HIV+)
Time frame: Baseline, 3 and 6 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.